Clinical Trials
4 trialsNCT04472286 2024-08-30
HBHL
University of Nebraska
Completed
NCT02434484 2021-01-26
Symbenda Post-Marketing Surveillance (PMS)
Eisai Inc.
Completed
NCT02885038 2017-10-02
TCP
Etablissement Français du Sang
Completed
NCT02461316 2016-11-02
Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia
Hoffmann-La Roche
Completed